Advisor Group Holdings, Inc. Soligenix, Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.61 - $0.75 $915 - $1,125	-1,500 Reduced 54.43%	1,256 $1,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $2.61 $2,550 - $3,915	1,500 Added 119.43%	2,756 $5,000
Q2 2020 Aug 14, 2020	BUY	$1.36 - $2.26 $680 - $1,130	500 Added 66.14%	1,256 $3,000
Q1 2020 May 18, 2020	BUY	$1.42 - $3.34 $1,073 - $2,525	756 New	756 $1,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.